News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

News|Articles|May 3, 2013

Orally Disintegrating Tablets

Author(s)Cynthia A. Challener

Podcast interview with Nick Johnson, Strategic Marketing Director for Modified Release Technologies at Catalent Pharma Solutions

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Related Content

The FDA finalized a rule standardizing the NDC to a uniform, 12-digit format

Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers

July 2nd 2026

BioPhorum formed a group aimed at accelerating innovation across small molecule manufacturing

BioPhorum Unites 20 Organizations to Modernize Small Molecule Production

ByZachary Zubulake

July 1st 2026

Antibody drug conjugate in blue with four drug compounds linked to IgG immunoglobulin; ADC in blue against blue background 3d render | Image Credit: ©huenstructurebio.com -stock.adobe.com

Lonza Increases HPAPI Production at Visp Facility

BySusan Haigney

June 30th 2026

Pill with American flag wrapped around it and red ball inside | Image Credit: ©fabioberti.it -stock.adobe.com

FDA Chooses 7 Companies for PreCheck Pilot

BySusan Haigney

June 30th 2026

PharmTech Weekly Roundup—June 26, 2026

BySusan Haigney

June 29th 2026

Trending on Pharmaceutical Technology

FDA Chooses 7 Companies for PreCheck Pilot

Documentation Reliability Across Contractors: A Quality Systems Approach

FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients

Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers

Regulatory Developments Impacting Biologics